Literature DB >> 33225397

Diagnostic accuracies of intraoperative frozen section and permanent section examinations for histological grades during open biopsy of bone tumors.

Shinji Miwa1, Norio Yamamoto2, Katsuhiro Hayashi2, Akihiko Takeuchi2, Kentaro Igarashi2, Kaoru Tada2, Takashi Higuchi2, Hirotaka Yonezawa2, Sei Morinaga2, Yoshihiro Araki2, Yohei Asano2, Hiroko Ikeda2, Takayuki Nojima2,3, Hiroyuki Tsuchiya2.   

Abstract

BACKGROUND: A histological diagnosis obtained from an intraoperative frozen section (FS) during biopsy confirms the adequacy of tumor tissue in the specimen. However, some cases show a discrepancy among the intraoperative FS diagnosis, permanent section (PS) diagnosis of the biopsy specimen, and the final diagnosis of the excised tumor specimen. In this study, we retrospectively investigated the diagnostic accuracy of the FS and PS for different types of bone tumors.
METHODS: This study included 377 patients with 411 bone tumors who underwent tumor excision after an open biopsy with intraoperative FS diagnosis. FS, PS, and final diagnoses of the patients were classified into benign tumors/tumor-like lesions, intermediate malignancies, and malignant tumors. To assess diagnostic accuracy, the histological grades in FS and PS diagnoses were compared with those in the final diagnoses.
RESULTS: The overall diagnostic accuracies of FS and PS were 93% and 97%, respectively. The accuracy of FS and PS for histological grade was 84% and 93% for chondrogenic tumors, 90% and 96% for osteogenic tumors, 97% and 98% for osteoclastic giant cell-rich tumors, 100% and 100% for tumors of undefined neoplastic nature, and 95% and 99% for other bone tumors, respectively.
CONCLUSION: These data suggest that surgical planning based on PS diagnosis is recommended for chondrogenic and osteogenic tumors.

Entities:  

Keywords:  Accuracy; Bone tumor; Frozen section diagnosis; Histological grade

Year:  2020        PMID: 33225397     DOI: 10.1007/s10147-020-01836-1

Source DB:  PubMed          Journal:  Int J Clin Oncol        ISSN: 1341-9625            Impact factor:   3.402


  21 in total

1.  Surgical biopsy with intra-operative frozen section. An accurate and cost-effective method for diagnosis of musculoskeletal sarcomas.

Authors:  R U Ashford; S W McCarthy; R A Scolyer; S F Bonar; R Z Karim; P D Stalley
Journal:  J Bone Joint Surg Br       Date:  2006-09

2.  The diagnostic value of needle biopsy for musculoskeletal lesions.

Authors:  Ki-Sun Sung; Sung-Wook Seo; Min-Soo Shon
Journal:  Int Orthop       Date:  2009-08-05       Impact factor: 3.075

3.  Diagnostic accuracy and clinical utility of biopsy in musculoskeletal lesions: a comparison of fine-needle aspiration, core, and open biopsy techniques.

Authors:  Lester J Layfield; Robert L Schmidt; Nikhil Sangle; Julia R Crim
Journal:  Diagn Cytopathol       Date:  2014-03-19       Impact factor: 1.582

4.  Ten thousand consecutive frozen sections. A retrospective study focusing on accuracy and quality control.

Authors:  W J Holaday; D Assor
Journal:  Am J Clin Pathol       Date:  1974-06       Impact factor: 2.493

5.  Can computer navigation-assisted surgery reduce the risk of an intralesional margin and reduce the rate of local recurrence in patients with a tumour of the pelvis or sacrum?

Authors:  L Jeys; G S Matharu; R S Nandra; R J Grimer
Journal:  Bone Joint J       Date:  2013-10       Impact factor: 5.082

Review 6.  Surgical options for children with osteosarcoma.

Authors:  Robert J Grimer
Journal:  Lancet Oncol       Date:  2005-02       Impact factor: 41.316

7.  Comparative study of diagnostic accuracy between office-based closed needle biopsy and open incisional biopsy in patients with musculoskeletal sarcomas.

Authors:  Phutsapong Srisawat; Puwadol Veeraphun; Thipachart Punyaratabandhu; Supichai Chareonvareekul; Thawee Songpattanasilpa; Pipat Sritanabutr; Sahachart Pipithkul
Journal:  J Med Assoc Thai       Date:  2014-02

8.  Percutaneous guided biopsy for diagnosing suspected primary malignant bone tumors in pediatric patients: a safe, accurate, and cost-saving procedure.

Authors:  Antony Ceraulo; Antoine Ouziel; Emilie Lavergne; Lionel Perrier; Anne-Valérie Decouvelaere; Franck Chotel; Philippe Thiesse; Perrine Marec-Berard
Journal:  Pediatr Radiol       Date:  2016-12-10

9.  Diagnostic accuracy and charge-savings of outpatient core needle biopsy compared with open biopsy of musculoskeletal tumors.

Authors:  M C Skrzynski; J S Biermann; A Montag; M A Simon
Journal:  J Bone Joint Surg Am       Date:  1996-05       Impact factor: 5.284

10.  Accuracy of intraoperative pathological diagnosis using frozen sections of spinal cord lesions.

Authors:  Kazuyoshi Kobayashi; Kei Ando; Kenyu Ito; Mikito Tsushima; Masayoshi Morozumi; Satoshi Tanaka; Masaaki Machino; Kyotaro Ota; Naoki Ishiguro; Shiro Imagama
Journal:  Clin Neurol Neurosurg       Date:  2018-02-16       Impact factor: 1.876

View more
  2 in total

1.  Stereotactic ablative radiotherapy in castration-resistant prostate cancer patients with oligoprogression during androgen receptor-targeted therapy.

Authors:  G Ingrosso; B Detti; A Fodor; S Caini; S Borghesi; L Triggiani; F Trippa; D Russo; A Bruni; G Francolini; A Lancia; L Marinelli; N Di Muzio; L Livi; S M Magrini; E Maranzano; D Musio; C Aristei; M Valeriani
Journal:  Clin Transl Oncol       Date:  2021-01-25       Impact factor: 3.405

2.  Pre-pembrolizumab neutrophil-to-lymphocyte ratio (NLR) predicts the efficacy of second-line pembrolizumab treatment in urothelial cancer regardless of the pre-chemo NLR.

Authors:  Takashi Kobayashi; Katsuhiro Ito; Takahiro Kojima; Satoru Maruyama; Shoichiro Mukai; Masakazu Tsutsumi; Jun Miki; Tomoya Okuno; Yuko Yoshio; Hiroaki Matsumoto; Toru Shimazui; Takehiko Segawa; Takashi Karashima; Kimihiko Masui; Fumimasa Fukuta; Kojiro Tashiro; Kazuto Imai; Shigetaka Suekane; Seiji Nagasawa; Shin Higashi; Tomohiro Fukui; Osamu Ogawa; Hiroshi Kitamura; Hiroyuki Nishiyama
Journal:  Cancer Immunol Immunother       Date:  2021-07-07       Impact factor: 6.968

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.